Comparison of characteristics and outcomes of young-onset versus average onset pancreatico-biliary adenocarcinoma

被引:6
|
作者
Jayakrishnan, Thejus [1 ]
Nair, Kanika G. [1 ]
Kamath, Suneel D. [1 ]
Wei, Wei [2 ]
Estfan, Bassam N. [1 ]
Krishnamurthi, Smitha S. [1 ]
Khorana, Alok A. [1 ,3 ]
机构
[1] Cleveland Clin, Taussig Canc Inst, Cleveland, OH USA
[2] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH USA
[3] Cleveland Clin, Taussig Canc Inst, 10201 Carnegie Ave CA60, Cleveland, OH 44195 USA
来源
CANCER MEDICINE | 2023年 / 12卷 / 06期
关键词
biliary cancers; cholangiocarcinoma; disparity; epidemiology; pancreatic adenocarcinoma; young-onset cancers; SOCIOECONOMIC-FACTORS; CANCER; STATES;
D O I
10.1002/cam4.5418
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundYoung-onset gastrointestinal malignancies appear to be increasing in incidence. There are limited data on young-onset pancreaticobiliary adenocarcinoma (YO-PBA). MethodsThe study comprised patients with PBA (pancreatic adenocarcinoma, intra-, and extra-hepatic cholangiocarcinoma) and included in the National Cancer Database (NCDB) between 2004 and 2017. YO-PBA was defined as a diagnosis at age less than 50 years. Logistic regression to assess factors associated with YO-PBA status, and cox proportional hazards modeling to associate relevant factors with overall survival was performed. ResultsThe study cohort comprised 360,764 patients, with 20,822 (5.8%) YO-PBA. YO-PBA was associated with (p-values<0.0001 for all): male sex (6.3% YO-male out of all male patients vs. 5.2% YO-female, OR 1.29, 95% CI 1.25-1.33), Black race (7.9% YO-Black vs. 5.0% YO-White, OR 1.72, 95% CI 1.64-1.80), lower income (6.4% YO-lowest household income based group vs. 5.5% highest, OR 1.08, 95% CI 1.03-1.13). YO-PBA were more likely to present with stage-IV disease (6.4% YO-Stage IV of all stage IV vs. 5.4% YO-Stage I-III, OR 1.25, 95% CI 1.21-1.29 p-value < 0.0001). Factors associated with overall survival (OS) in non-operable patients included-sex - male vs. female, HR 1.12 (95% CI 1.08-1.15); race - Black vs. White, HR 1.23 (95% CI 1.06-1.42); income group - lowest vs. highest, HR 1.33 (95% CI 1.27-1.39), and treatment center type - academic vs. nonacademic center, HR 0.87 (95% CI 0.85-0.90). ConclusionsSocioeconomic factors significantly impact incidence and outcomes for young-onset pancreaticobiliary adenocarcinoma (YO-PBA). More work is needed to help understand the mechanisms involved while addressing the disparities.
引用
收藏
页码:7327 / 7338
页数:12
相关论文
共 50 条
  • [1] Comparison of characteristics and outcomes of young-onset versus average onset pancreatico-biliary adenocarcinoma (vol 12, pg 7327, 2023)
    Jayakrishnan, T.
    Nair, N. G.
    Kamath, S. D.
    CANCER MEDICINE, 2023, 12 (14): : 15762 - 15762
  • [2] Comparison of characteristics and outcomes of young onset versus average onset pancreatobiliary adenocarcinoma.
    Jayakrishnan, Thejus
    Kamath, Suneel Deepak
    Nair, Kanika G.
    Wei, Wei
    Estfan, Bassam N.
    Krishnamurthi, Smitha S.
    Khorana, Alok A.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [3] Characteristics and outcomes of patients with young-onset versus average-onset cholangiocarcinoma in the United States
    Grewal, Udhayvir Singh
    Dhaduk, Rikeenkumar
    Patel, Sagar
    Singh, Achintya D.
    Chau, Justin James
    Chakrabarti, Sakti
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [4] Metabolomic differences in young-onset versus average-onset colorectal adenocarcinoma.
    Jayakrishnan, Thejus
    Farha, Nicole
    Mariam, Arshiya
    Rotroff, Daniel Miller
    Aucejo, Federico
    Barot, Shimoli V.
    Conces, Madison
    Nair, Kanika G.
    Krishnamurthi, Smitha S.
    Schmit, Stephanie
    Liska, David
    Khorana, Alok A.
    Kamath, Suneel Deepak
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 174 - 174
  • [5] Metabolomic differences in young-onset versus average-onset colorectal adenocarcinoma.
    Jayakrishnan, Thejus
    Farha, Nicole
    Mariam, Arshiya
    Rotroff, Daniel Miller
    Aucejo, Federico
    Barot, Shimoli V.
    Conces, Madison
    Nair, Kanika G.
    Krishnamurthi, Smitha S.
    Schmit, Stephanie
    Liska, David
    Khorana, Alok A.
    Kamath, Suneel Deepak
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [6] Characteristics and clinical outcomes in young-onset cholangiocarcinoma
    Reddy, Sarah
    Goksu, Suleyman Yasin
    Sanford, Nina N.
    Kainthla, Radhika
    Hsiehchen, David
    Sanjeevaiah, Aravind
    Jones, Amy L.
    Karagkounis, Georgios
    Al Mutar, Salwan
    Ahn, Chul
    Beg, Muhammad S.
    Kazmi, Syed M.
    CANCER MEDICINE, 2023, 12 (13): : 14094 - 14103
  • [7] Comparison of comprehensive genomic profiles between young-onset and average-onset colorectal cancer
    Torrejon, Nataly Valeria
    Deshpande, Saarang
    Wei, Wei
    Tullio, Katherine
    Barot, Shimoli V.
    Nair, Kanika G.
    Krishnamurthi, Smitha S.
    Schmit, Stephanie
    Liska, David
    Khorana, Alok A.
    Kamath, Suneel Deepak
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [8] Clinical, genomic and transcriptomic characteristics of young-onset biliary tract cancers
    Pudlarz, T.
    Antoun, L.
    Rousseau, A.
    Nicolle, R.
    Gelli, M.
    de Sevilla, E. Fernandez
    Cosconea, S.
    Tselikas, L.
    Barbe, R.
    Turpin, A.
    Deloger, M.
    Italiano, A.
    Valery, M.
    Tarabay, A. A.
    Boige, V.
    Malka, D.
    Smolenschi, C.
    Hollebecque, A.
    Ducreux, M. P.
    Boileve, A.
    ANNALS OF ONCOLOGY, 2023, 34 : S224 - S224
  • [9] Clinical Characteristics and Outcomes in Young-Onset Multiple System Atrophy
    Badihian, Negin
    Savica, Rodolfo
    Adler, Charles H.
    Wszolek, Zbigniew K.
    Jackson, Lauren M.
    Benarroch, Eduardo E.
    Sandroni, Paola
    Low, Phillip A.
    Singer, Wolfgang
    Coon, Elizabeth A.
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2024, 11 (03): : 220 - 226
  • [10] Distinct intratumoral microbiome of young-onset and average-onset colorectal cancer
    Barot, Shimoli V.
    Sangwan, Naseer
    Nair, Kanika G.
    Schmit, Stephanie L.
    Xiang, Shao
    Kamath, Suneel
    Liska, David
    Khorana, Alok A.
    EBIOMEDICINE, 2024, 100